146 related articles for article (PubMed ID: 38554384)
21. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
22. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
Cheng Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
[TBL] [Abstract][Full Text] [Related]
23. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling.
Li TH; Zhao BB; Qin C; Wang YY; Li ZR; Cao HT; Yang XY; Zhou XT; Wang WB
Cell Oncol (Dordr); 2021 Dec; 44(6):1425-1437. PubMed ID: 34791638
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
[TBL] [Abstract][Full Text] [Related]
25. LncNEN885 inhibits epithelial-mesenchymal transition by partially regulation of Wnt/β-catenin signalling in gastroenteropancreatic neuroendocrine neoplasms.
Wei YL; Hua J; Liu XY; Hua XM; Sun C; Bai JA; Tang QY
Cancer Sci; 2018 Oct; 109(10):3139-3148. PubMed ID: 30033597
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
[TBL] [Abstract][Full Text] [Related]
27. LncRNA H19 Promoted the Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer via Activating Wnt/β-Catenin Signaling.
Liu J; Wang G; Zhao J; Liu X; Zhang K; Gong G; Pan H; Jiang Z
Dig Dis; 2022; 40(4):436-447. PubMed ID: 34348271
[TBL] [Abstract][Full Text] [Related]
28. [
Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
[TBL] [Abstract][Full Text] [Related]
29. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
30. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
31. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
Guo F; Zhu X; Zhao Q; Huang Q
Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
[TBL] [Abstract][Full Text] [Related]
32. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.
Weng YC; Ma J; Zhang J; Wang JC
Cancer Biol Ther; 2019; 20(3):368-380. PubMed ID: 30580676
[TBL] [Abstract][Full Text] [Related]
35. lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/β-catenin signaling pathway.
Liu S; Yang N; Wang L; Wei B; Chen J; Gao Y
J Cell Physiol; 2020 Oct; 235(10):7541-7553. PubMed ID: 32239719
[TBL] [Abstract][Full Text] [Related]
36. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
38. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
Bi W; Yang M; Xing P; Huang T
Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
[TBL] [Abstract][Full Text] [Related]
40. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
